For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Covid-19 Vaccines For Kids: DCGI Grants Emergency Use Nod To 3 Vaccines For Different Age Group Of Children

On Tuesday (26 April), the Drugs Controller General of India (DCGI) approved three Covid-19 vaccines for restricted emergency use authorisation (EUA) in children of various ages.

DCGI Grants Emergency Use Nod To 3 Vaccines

Bharat Biotech's Covaxin received a restricted EUA from the DCGI for children aged 6 to12. Similarly, Biological E's Covid-19 vaccine Corbevax has been approved for children aged 5 to 12 years.

Further, along with Corbevax and Covaxin, the DCGI has also approved Zydus Cadila's Covid-19 vaccine ZyCoV-D for children over the age of 12 years for a two-dose regimen.

This development happened after the Subject Expert Committee's (SEC) discussion of suggestions for the emergency use of Covaxin in children aged 6 to 12 years due to an increase in covid-19 cases in schools.

DCGI Grants Emergency Use Nod To 3 Vaccines

Covaxin has proven to be effective for adults and is also presently being given to youngsters aged 15 to 18. To give EUA to Covaxin for children aged 6-12 years, experts had requested more information from the corporation, which was delivered on Friday. The SEC was satisfied with the provided data and thus, nods for its EUA among children aged 6-12 years.

As the focus was mainly on the increasing number of cases among children, the SEC has also recommended emergency use of Biological E's Covid-19 vaccine Corbevax and ZyCoV-D.

Story first published: Wednesday, April 27, 2022, 8:00 [IST]